Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 13890
Country/Region: Zimbabwe
Year: 2017
Main Partner: Organisation for Public Health Interventions and Development
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: USAID
Total Funding: $12,269,937 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $3,094,467
Care: TB/HIV (HVTB) $862,837
Care: Pediatric Care and Support (PDCS) $166,672
Strategic Information (HVSI) $46,169
Testing: HIV Testing and Counseling (HVCT) $2,334,549
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $113,863
Treatment: Adult Treatment (HTXS) $5,525,333
Treatment: Pediatric Treatment (PDTX) $126,047
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 416,129
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 616,235
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 19,610
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 30,735
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 49,746
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 6
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 8,923
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 2,309
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 2,314
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 409
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 741
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 405
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 743
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 6
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 10,488
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 8
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 10,465
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 1,287
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 1,294
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 15,491
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 48,874
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 13,592
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 13,561
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 7,061
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 12,575
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 7,062
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 12,632
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 125,826
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 127,218
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 21,111
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 21,259
HTS_TST Service Delivery Point (Facility) Inpatient: Unknown Age, Female, Negative 2018 46
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 10,435
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 134
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 2,712
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 35
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 2,614
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 35
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 3,478
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 28
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 5,716
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 14
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 3,561
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 28
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 5,930
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 14
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 89,770
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 915
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 93,288
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 404
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 11,215
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 78
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 11,263
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 92
HTS_TST Service Delivery Point (Facility) Other PITC: Unknown Age, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 34,019
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 132
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 270
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 23
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 131
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 269
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 23
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 4,833
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 126
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 5,201
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 216
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 557
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 18
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 555
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 18
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 16
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 4
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 11
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 2
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 11
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 2
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 225
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 124
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 21
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 21
HTS_TST Service Delivery Point (Facility) VMMC: 1-9, Negative 2018 4
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2018 1
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 30
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 46,250
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 26
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 39,102
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 30
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 45,599
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 9
HTS_TST Sum of Test Result disaggregates 2018 35,971
HTS_TST Sum of Test Result disaggregates 2018 76,685
HTS_TST_POS By Test Result: Positive 2018 35,971
HTS_TST_POS By Test Result: Positive 2018 76,685
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 1,635
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 2,418
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 3,906
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 200
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 139
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 290
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 146
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 302
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 4,489
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 4,477
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 511
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 518
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 428
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 2,209
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 507
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 507
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 775
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 1,376
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 777
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 1,374
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 20,474
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 22,949
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 2,655
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 2,675
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 251
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 50
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 50
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 357
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 621
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 408
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 691
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 9,925
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 101
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 10,296
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 45
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 1,240
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 1,244
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 1,030
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 140
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 268
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 139
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 271
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 4,607
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 124
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 4,839
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 218
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 540
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 557
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 25
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: Unknown Age, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 511
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 429
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 502
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 3
PMTCT_ART Already on ART at beginning of current pregnancy 2018 8,528
PMTCT_ART Already on ART at beginning of current pregnancy 2018 5
PMTCT_ART New on ART 2018 7,022
PMTCT_ART New on ART 2018 4
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 15,550
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 9
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 113,602
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 2,752
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 13,437
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 3,200
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 3,095
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 613
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 7,783
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,465
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 375
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 85
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 47
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 37
PMTCT_EID Unknown, <= 2 months 2018 1,949
PMTCT_EID Unknown, 2 - 12 months 2018 188
PMTCT_STAT By Age (Numerator): : 15-19 2018 13,665
PMTCT_STAT By Age (Numerator): <10 2018 1
PMTCT_STAT By Age (Numerator): 10-14 2018 170
PMTCT_STAT By Age (Numerator): 10-14 2018 6
PMTCT_STAT By Age (Numerator): 15-19 2018 235
PMTCT_STAT By Age (Numerator): 20-24 2018 28,111
PMTCT_STAT By Age (Numerator): 20-24 2018 586
PMTCT_STAT By Age (Numerator): 25-49 2018 71,606
PMTCT_STAT By Age (Numerator): 25-49 2018 1,904
PMTCT_STAT By Age (Numerator): 50+ 2018 48
PMTCT_STAT By Age (Numerator): 50+ 2018 2
PMTCT_STAT By known positives: 10-14 2018 21
PMTCT_STAT By known positives: 15-19 2018 845
PMTCT_STAT By known positives: 20-24 2018 1,879
PMTCT_STAT By known positives: 25-49 2018 5,274
PMTCT_STAT By known positives: 50+ 2018 9
PMTCT_STAT By new negatives: <10 2018 1
PMTCT_STAT By new negatives: 10-14 2018 122
PMTCT_STAT By new negatives: 15-19 2018 11,860
PMTCT_STAT By new negatives: 20-24 2018 24,333
PMTCT_STAT By new negatives: 25-49 2018 61,521
PMTCT_STAT By new negatives: 50+ 2018 45
PMTCT_STAT By new positives: 10-14 2018 12
PMTCT_STAT By new positives: 15-19 2018 820
PMTCT_STAT By new positives: 20-24 2018 1,712
PMTCT_STAT By new positives: 25-49 2018 4,487
PMTCT_STAT By new positives: 50+ 2018 4
PMTCT_STAT By Number of known positives: 15-19 2018 20
PMTCT_STAT By Number of known positives: 20-24 2018 52
PMTCT_STAT By Number of known positives: 25-49 2018 168
PMTCT_STAT By Number of known positives: 50+ 2018 6
PMTCT_STAT By Number of new negative: 10-14 2018 5
PMTCT_STAT By Number of new negative: 15-19 2018 196
PMTCT_STAT By Number of new negative: 20-24 2018 486
PMTCT_STAT By Number of new negative: 25-49 2018 1,552
PMTCT_STAT By Number of new negative: 50+ 2018 17
PMTCT_STAT By Number of new positives: 15-19 2018 20
PMTCT_STAT By Number of new positives: 20-24 2018 52
PMTCT_STAT By Number of new positives: 25-49 2018 169
PMTCT_STAT By Number of new positives: 50+ 2018 6
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 113,602
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 2,752
PMTCT_STAT_den By Age (Denominator): 10-14 2018 15
PMTCT_STAT_den By Age (Denominator): 15-19 2018 23,644
PMTCT_STAT_den By Age (Denominator): 20-24 2018 36,890
PMTCT_STAT_den By Age (Denominator): 25-49 2018 59,529
PMTCT_STAT_den By Age (Denominator): 50+ 2018 105
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 138
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 2,518
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 200
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3,736
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 9,877
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 6,596
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 218
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 3,768
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 308
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 5,579
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 142
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 4,132
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 248
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 6,154
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 10,667
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 10,727
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 142
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 4,134
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 256
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 6,215
TX_CURR Age/Sex: <1 2018 1,506
TX_CURR Age/Sex: <1 2018 2
TX_CURR Age/Sex: <1-9 2018 33
TX_CURR Age/Sex: 1-9 2018 19,613
TX_CURR Age/Sex: 10-14 Female 2018 8,138
TX_CURR Age/Sex: 10-14 Female 2018 10
TX_CURR Age/Sex: 10-14 Male 2018 7,726
TX_CURR Age/Sex: 10-14 Male 2018 9
TX_CURR Age/Sex: 15-19 Female 2018 10,926
TX_CURR Age/Sex: 15-19 Female 2018 3,982
TX_CURR Age/Sex: 15-19 Male 2018 6,102
TX_CURR Age/Sex: 15-19 Male 2018 2,159
TX_CURR Age/Sex: 20-24 Female 2018 27,404
TX_CURR Age/Sex: 20-24 Female 2018 9,831
TX_CURR Age/Sex: 20-24 Male 2018 12,029
TX_CURR Age/Sex: 20-24 Male 2018 3,855
TX_CURR Age/Sex: 25-49 Female 2018 147,900
TX_CURR Age/Sex: 25-49 Female 2018 64,624
TX_CURR Age/Sex: 25-49 Male 2018 81,763
TX_CURR Age/Sex: 25-49 Male 2018 34,259
TX_CURR Age/Sex: 50+ Female 2018 33,247
TX_CURR Age/Sex: 50+ Female 2018 13,519
TX_CURR Age/Sex: 50+ Male 2018 25,423
TX_CURR Age/Sex: 50+ Male 2018 10,599
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 382,108
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 143,940
TX_CURR Sum of age/sex disaggregates 2018 6,141
TX_CURR Sum of Age/Sex disaggregations 2018 17,028
TX_NEW Breastfeeding status 2018 4,366
TX_NEW By Age/Sex: <1 2018 940
TX_NEW By Age/Sex: 1-9 2018 2,868
TX_NEW By Age/Sex: 1-9 2018 13
TX_NEW By Age/Sex: 10-14 Female 2018 529
TX_NEW By Age/Sex: 10-14 Female 2018 6
TX_NEW By Age/Sex: 10-14 Male 2018 570
TX_NEW By Age/Sex: 10-14 Male 2018 6
TX_NEW By Age/Sex: 15-19 Female 2018 2,443
TX_NEW By Age/Sex: 15-19 Female 2018 534
TX_NEW By Age/Sex: 15-19 Male 2018 843
TX_NEW By Age/Sex: 15-19 Male 2018 555
TX_NEW By Age/Sex: 20-24 Female 2018 7,236
TX_NEW By Age/Sex: 20-24 Female 2018 529
TX_NEW By Age/Sex: 20-24 Male 2018 1,827
TX_NEW By Age/Sex: 20-24 Male 2018 551
TX_NEW By Age/Sex: 25-49 Female 2018 43,317
TX_NEW By Age/Sex: 25-49 Female 2018 11,677
TX_NEW By Age/Sex: 25-49 Male 2018 29,531
TX_NEW By Age/Sex: 25-49 Male 2018 8,952
TX_NEW By Age/Sex: 50+ Female 2018 6,510
TX_NEW By Age/Sex: 50+ Female 2018 1,187
TX_NEW By Age/Sex: 50+ Male 2018 6,094
TX_NEW By Age/Sex: 50+ Male 2018 1,195
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 102,713
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 25,463
TX_NEW Pregnancy status 2018 3,545
TX_NEW Sum of Age/Sex disaggregates 2018 98,900
TX_NEW Sum of Age/Sex disaggregates 2018 25,192
TX_PVLS <15, Routine, Unknown Sex 2018 5
TX_PVLS <15, Targeted, Unknown Sex 2018 1
TX_PVLS 15+, Routine, Unknown Sex 2018 98
TX_PVLS 15+, Targeted, Unknown Sex 2018 11
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 69
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 458,803
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 413,933
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 13,492
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 1,571
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 13,832
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1,577
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 222,305
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 24,618
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 122,905
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 13,617
TX_PVLS Numerator: Indication: Routine 2018 372,529
TX_PVLS Numerator: Indication: Targeted 2018 41,404
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 631
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 72
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 5,703
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 627
TX_PVLS Unknown Age, Targeted, Female 2018 4
TX_PVLS Unknown Age, Targeted, Female 2018 16
TX_PVLS Unknown Age, Targeted, Male 2018 5
TX_PVLS Unknown Age, Targeted, Male 2018 16
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 14,942
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 1,845
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 14,747
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1,741
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 245,871
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 27,204
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 136,215
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 15,024
TX_PVLS_den Denominator: Indication: Routine 2018 409,336
TX_PVLS_den Denominator: Indication: Targeted 2018 45,884
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 686
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 48
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 6,310
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 685
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 15,007
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 15,391
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 245,918
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 136,571
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 412,983
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 458,828
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 16,555
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 17,162
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 274,461
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 151,715
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 447,349
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 44,747
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 1,628
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 26,716
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 1,577
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 14,811
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 16,721
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 263,024
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 16,123
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 148,061
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 10,662
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 88
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 10,635
TX_TB_den Denominator: By Screen Result: Negative 2018 424,537
TX_TB_den Denominator: By Screen Result: Positive 2018 22,362
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 21,335
Cross Cutting Budget Categories and Known Amounts Total: $2,806,366
Key Populations: Sex Workers $400,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Key Populations: MSM and TG $100,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Food and Nutrition: Policy, Tools, and Service Delivery $316,866
Water $50,000
Human Resources for Health $1,939,500